Hyperthermia: Clinical Trials

3 trials for Hyperthermia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 21Terminated 1

Follow Hyperthermia: new trials by email Literature Review of Hyperthermia trials Research Report on Hyperthermia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan
HECT-CL - Cutaneous Leishmaniases
Phase 3TerminatedMedecins Sans Frontieres, Netherlands562017-10-042019-01-16
Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)
Dantrolene, Placebo - Hyperthermia
Phase 2 / Phase 3TerminatedMedical University of Vienna342008-05-012011-05-12
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer
Synergo + MMC, Bacillus Calmette-Guérin - Urinary Bladder Diseases, Urinary Bladder Neoplasms
Phase 3TerminatedMedical Enterprises Europe B.V.1902002-02-012014-10-07

Narrower conditions

Leishmaniasis, Cutaneous (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Non-Muscle Invasive Bladder Neoplasms (1)  ·  Urinary Bladder Diseases (1)  ·  Urinary Bladder Neoplasms (1)  ·  Urologic Diseases (1)  ·  Urologic Neoplasms (1)

Broader conditions

Body Temperature Changes (3)  ·  Heat Stress Disorders (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Wounds and Injuries (3)  ·  Carcinoma (1)  ·  Euglenozoa Infections (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Infections (1)  ·  Leishmaniasis (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Parasitic Diseases (1)

Interventions

Dantrolene (1)

Sponsors

Medecins Sans Frontieres, Netherlands (1)  ·  Medical Enterprises Europe B.V. (1)  ·  Medical University of Vienna (1)

Countries

Austria (2)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Pakistan (1)

Top investigators

Alfred A Witjes, MD PhD (1)  ·  Andrea Holzer, MD (1)  ·  Koert Ritmeijer, PhD (1)

Results publications

PMID 26803476